100 matches for your search in the start-up spotlight
rss
Breakthrough antibody therapies target the roots of inflammation and promise breakthroughs for millions of patients
30-Apr-2025
Granite Bio AG has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures. Granite’s pipeline features two first-in-class antibodies ...
Results in seconds rather than hours: Groundbreaking instrument-free assay nears completion
14-Apr-2025
Chemeleon, a disruptive innovator in diagnostic technology, announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on ...
Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth (CMT) disease
31-Mar-2025
Augustine Therapeutics NV, a biotechnology company focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enzyme, announced it has successfully completed its Series A financing ...
10-Mar-2025
Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round. This financing was led by Frazier Life Sciences with ...
Patented cell reprogramming technology "addicts" cells to high production and integrates seamlessly into any microbial bioproduction host
11-Feb-2025
Enduro Genetics – the synthetic biology startup transforming biomanufacturing by “addicting” cells to high production – has raised €12 million in Series A funding from Supernova Invest, NOON Ventures and Sandwater. The funding will be used to expand Enduro’s platform and scale ...
Funding will accelerate the company's anti-amyloid treatment for rare and common forms of dementia
27-Jan-2025
Icelandic drug discovery and development company Arctic Therapeutics (ATx) announced the successful closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of international investors. The syndicate includes the EIC Fund, Iceland's largest privately-held investment firm ...
GET Fund and Schaeffler AG invest in young Mainz-based company
16-Jan-2025
The German start-upCircunomics GmbH (based in Mainz) successfully closed its Series A financing round in December 2024, raising over eight million euros from significant investors. Founded in 2019, the company promotes the circular economy for lithium-ion batteries by advancing ...
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
10-Dec-2024
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, ...
UpNano receives capital boost for further advancing high-end 2PP 3D printers, materials, and services
21-Oct-2024
UpNano GmbH (Vienna, Austria) announced the completion of its EUR 7M Series A round co-led by aws Gründungsfonds, Novacapital and IGO Innovation GmbH. The funds raised will allow UpNano to accelerate the development of its next generation 2-photon polymerization (2PP) 3D printing technology at a ...
16-Oct-2024
invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, announced that the company has raised €8.2 million in a Series A fundraising that includes strong participation from existing shareholders and Ligand Pharmaceuticals. Ligand recently acquired APEIRON, the ...
